Carroll Financial Associates’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-15
Closed -$825 1976
2021
Q3
$0 Hold
15
﹤0.01% 1973
2021
Q2
$0 Buy
+15
New +$988 ﹤0.01% 1869
2020
Q1
Sell
-270
Closed -$15K 1706
2019
Q4
$15K Hold
270
﹤0.01% 957
2019
Q3
$14K Hold
270
﹤0.01% 924
2019
Q2
$15K Buy
+270
New +$14.5K ﹤0.01% 906
2019
Q1
Sell
-108
Closed -$4K 1533
2018
Q4
$4K Sell
108
-35
-24% -$1.27K ﹤0.01% 1105
2018
Q3
$5K Sell
143
-29
-17% -$1.21K ﹤0.01% 1104
2018
Q2
$7K Hold
172
﹤0.01% 966
2018
Q1
$8K Hold
172
﹤0.01% 901
2017
Q4
$11K Hold
172
﹤0.01% 815
2017
Q3
$10K Buy
172
+14
+9% +$832 ﹤0.01% 825
2017
Q2
$10K Buy
158
+88
+126% +$5.56K ﹤0.01% 840
2017
Q1
$4K Buy
+70
New +$4.21K ﹤0.01% 1027

Other funds holding XRAY

Carroll Financial Associates's XRAY Position: Q4 2021 in Review

Carroll Financial Associates sold out of Dentsply Sirona (XRAY) in Q4 2021, closing a stake of 15 shares — an estimated $825 sold.

Carroll Financial Associates first reported a position in XRAY in Q1 2017 and held it in 13 quarters. The position peaked at $15K in Q4 2019. 543 funds tracked by Wall St. Rank hold XRAY as of Q4 2021.

  • Carroll Financial Associates reported no remaining Dentsply Sirona position as of Q4 2021 after selling out during the quarter.
  • Carroll Financial Associates sold 15 Dentsply Sirona shares in Q4 2021, an estimated $825.
  • Carroll Financial Associates first reported a position in Dentsply Sirona in Q1 2017 and held it in 13 quarters.
  • Carroll Financial Associates's Dentsply Sirona position peaked at $15K in Q4 2019.
  • 543 funds tracked by Wall St. Rank held Dentsply Sirona as of Q4 2021.

Based on Carroll Financial Associates's 13F filing for Q4 2021, filed 6 Jan 2022.